Smith & Nephew Denies Discussion of Mergers or Takeovers

Smith & Nephew has officially denied having discussions on the sale of the company, according to a report from The New York Times.

The Telegraph previously reported that Biomet would begin informal talks about a potential merger with Smith & Nephew. Sky News also reported earlier in the week that Smith & Nephew had rejected an $11 billion takeover from Johnson & Johnson in December. Stock prices jumped and then retreated after this announcement was made.

Smith & Nephew has an enterprise value of $10.3 billion. The company issued a statement today clarifying that it is not engaging in any discussions which could lead to a merger or takeover.

Read the Smith & Nephew release on the denial of mergers or acquisitions.

Read the report from The New York Times about Smith & Nephew.

Read other coverage on Smith & Nephew:

- Smith & Nephew Shares Jump After Rejecting Johnson & Johnson Acquisition

- Smith & Nephew Responds to FDA Letter of Warning

- Smith & Nephew Adds 100 Employees

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers